chemotherapy

chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells, and it has been developed by Sidney Farber, Emil Frei, and James Holland at the National Cancer Institute and Dana-Farber Cancer Institute. The concept of chemotherapy was first introduced by Paul Ehrlich, a Nobel Prize winner, who discovered Salvarsan, an arsenic-based drug used to treat syphilis, and later developed by Alexander Fleming, who discovered penicillin, and Selman Waksman, who discovered streptomycin. The development of chemotherapy as a cancer treatment was also influenced by the work of Louis Pasteur, Robert Koch, and Gertrude Elion, who developed 6-mercaptopurine, a drug used to treat leukemia, at Burroughs Wellcome and Duke University. The use of chemotherapy has been supported by organizations such as the American Cancer Society, Cancer Research UK, and the National Cancer Institute, and has been used to treat patients at Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Stanford Cancer Institute.

History

The history of chemotherapy dates back to the early 20th century, when Paul Ehrlich and Alfred Bertheim developed the first chemotherapy drug, Salvarsan, at the Institute of Experimental Therapy in Frankfurt. The development of chemotherapy as a cancer treatment was also influenced by the work of Sidney Farber, who used aminopterin to treat leukemia at the Children's Hospital Boston and Harvard Medical School. The first successful chemotherapy treatment for cancer was developed by Emil Frei and James Holland at the National Cancer Institute and Roswell Park Comprehensive Cancer Center, using a combination of drugs including methotrexate, vincristine, and prednisone. The development of chemotherapy has also been influenced by the work of Jonas Salk, who developed the polio vaccine at the University of Pittsburgh, and Albert Sabin, who developed the oral polio vaccine at the Cincinnati Children's Hospital.

Types

There are several types of chemotherapy drugs, including alkylating agents such as cyclophosphamide and chlorambucil, which were developed by Alfred Gilman and Frederick Sutherland at the Yale University and Columbia University. Other types of chemotherapy drugs include antimetabolites such as 5-fluorouracil and capecitabine, which were developed by Charles Heidelberger at the University of Wisconsin-Madison and Roche Holding. Plant alkaloids such as vincristine and vinblastine are also used as chemotherapy drugs, and were developed by Robert Noble and Charles Beer at the University of Western Ontario and McMaster University. Hormone therapies such as tamoxifen and aromatase inhibitors are used to treat hormone-sensitive cancers, and were developed by V. Craig Jordan at the Worcester Foundation for Experimental Biology and Northwestern University.

Medical uses

Chemotherapy is used to treat a wide range of cancer types, including breast cancer, lung cancer, colon cancer, and leukemia, at institutions such as Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Stanford Cancer Institute. It is often used in combination with other treatments, such as surgery and radiation therapy, as part of a comprehensive treatment plan developed by oncologists such as David Livingston at the Dana-Farber Cancer Institute and Harvard Medical School. Chemotherapy can be used as a neoadjuvant therapy to shrink tumors before surgery, or as an adjuvant therapy to prevent cancer recurrence after surgery, as recommended by organizations such as the National Comprehensive Cancer Network and the European Society for Medical Oncology. Chemotherapy can also be used to treat cancer that has spread to other parts of the body, such as metastatic breast cancer or metastatic lung cancer, at institutions such as the University of Texas MD Anderson Cancer Center and the University of California, Los Angeles.

Administration

Chemotherapy can be administered through various routes, including intravenous injection, oral ingestion, and topical application, at institutions such as Cleveland Clinic and Johns Hopkins Hospital. The choice of administration route depends on the type of chemotherapy drug and the individual patient's needs, as determined by oncologists such as Vincent DeVita at the Yale Cancer Center and National Cancer Institute. Intravenous injection is the most common route of administration, and is often used to deliver chemotherapy drugs such as doxorubicin and paclitaxel, which were developed by Farmitalia Carlo Erba and Bristol-Myers Squibb. Oral ingestion is used to administer chemotherapy drugs such as capecitabine and temozolomide, which were developed by Roche Holding and Schering-Plough.

Side effects

Chemotherapy can cause a range of side effects, including nausea and vomiting, hair loss, and fatigue, which can be managed with drugs such as ondansetron and granisetron, developed by GlaxoSmithKline and Hoffmann-La Roche. Other side effects of chemotherapy include neutropenia, anemia, and thrombocytopenia, which can increase the risk of infection and bleeding, as reported by organizations such as the Centers for Disease Control and Prevention and the World Health Organization. Chemotherapy can also cause long-term side effects, such as infertility and cardiotoxicity, which can be managed with drugs such as clomiphene and beta blockers, developed by Merck & Co. and Pfizer. The management of side effects is an important part of chemotherapy treatment, and is often overseen by oncologists such as Larry Norton at the Memorial Sloan Kettering Cancer Center and Cornell University.

Mechanism of action

The mechanism of action of chemotherapy drugs varies depending on the type of drug and the type of cancer being treated, as described by scientists such as James Allison at the University of Texas MD Anderson Cancer Center and Howard Hughes Medical Institute. Alkylating agents work by damaging the DNA of cancer cells, preventing them from reproducing, as reported by researchers at the National Cancer Institute and University of California, San Francisco. Antimetabolites work by interfering with the production of nucleic acids and proteins in cancer cells, as described by scientists such as Gertrude Elion at the Duke University and Burroughs Wellcome. Plant alkaloids work by disrupting the microtubules of cancer cells, preventing them from dividing, as reported by researchers at the University of Wisconsin-Madison and McMaster University.

Development and research

The development of new chemotherapy drugs is an ongoing area of research, with many pharmaceutical companies such as Pfizer, Merck & Co., and Roche Holding investing in the development of new chemotherapy treatments, as reported by organizations such as the Pharmaceutical Research and Manufacturers of America and the European Federation of Pharmaceutical Industries and Associations. Researchers such as Charles Sawyers at the Memorial Sloan Kettering Cancer Center and Howard Hughes Medical Institute are working to develop new chemotherapy drugs that are more effective and have fewer side effects, as described by scientists such as Brian Druker at the Oregon Health & Science University and Novartis. The use of combination therapy, where multiple chemotherapy drugs are used together, is also being explored as a way to improve treatment outcomes, as reported by organizations such as the National Cancer Institute and the American Society of Clinical Oncology. Category:Cancer treatment